News EMA's post-Brexit location to be decided today The location of the European Medicines Agency after Brexit is to be decided today, as representatives of member states vote in a complex secret ballot that could end with a coin toss.
Views & Analysis Huge scale of Brexit threat to Europe’s medicines supplies r... New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.
News FDA takes big step towards manufacturing harmonisation with ... FDA agrees to recognise some EU inspections for the first time
Views & Analysis Pharma and med device sectors being forced into Hard Brexit ... Brexit is already forcing parts of the medical device sector to leave the UK – will pharma have to follow?
Views & Analysis PRIME movers: taking stock of the EMA's scheme Taking stock of one PRIME, of the EMA’s flagship market access initiatives.
News Bungled Brexit move would trigger public health crisis, warn... Regulator could be crippled by staff exodus during relocation.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.